Island Pharmaceuticals Limited

CHIA:ILA Stock Report

Market Cap: AU$28.1m

Island Pharmaceuticals Past Earnings Performance

Past criteria checks 0/6

Island Pharmaceuticals's earnings have been declining at an average annual rate of -17.2%, while the Pharmaceuticals industry saw earnings growing at 35.1% annually. Revenues have been growing at an average rate of 137.8% per year.

Key information

-17.2%

Earnings growth rate

28.9%

EPS growth rate

Pharmaceuticals Industry Growth31.2%
Revenue growth rate137.8%
Return on equity-188.6%
Net Margin-228.9%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Island Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CHIA:ILA Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241-320
31 Mar 241-320
31 Dec 231-221
30 Sep 230-321
30 Jun 230-320
31 Mar 230-320
31 Dec 220-321
30 Sep 220-321
30 Jun 220-321
31 Mar 220-321
31 Dec 210-330
30 Sep 210-320
30 Jun 210-220
30 Jun 200000
31 Dec 190-101

Quality Earnings: ILA is currently unprofitable.

Growing Profit Margin: ILA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ILA is unprofitable, and losses have increased over the past 5 years at a rate of 17.2% per year.

Accelerating Growth: Unable to compare ILA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ILA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (26.6%).


Return on Equity

High ROE: ILA has a negative Return on Equity (-188.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Island Pharmaceuticals Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rosemary CumminsMST Financial Services Pty Limited